WHITEHAWK THERAPEUTICS, INC. Accrued Liabilities, Current
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Accrued Liabilities, Current of $9.96 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Liabilities, Current $9.96M.
- 2026-03-31: Accrued Liabilities, Current $9.31M.
- 2025-12-31: Accrued Liabilities, Current $13.60M.
- 2025-09-30: Accrued Liabilities, Current $8.22M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $9.96M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $9.31M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $13.60M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $8.22M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $5.42M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $8.62M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $14.65M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $14.12M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $13.75M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $10.60M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $14.31M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $11.73M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $9.69M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $10.83M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $14.92M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $13.60M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $8.65M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $7.34M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $8.70M 10-K · filed 2023-03-29 | $8.45M 10-K · filed 2022-03-17 |
| 2021-09-30 | $6.25M 10-Q · filed 2021-11-10 | |
| 2020-12-31 | $4.10M 10-K · filed 2022-03-17 | |
| 2016-12-31 | $13.28K 10-K · filed 2017-03-07 | |
| 2016-09-30 | $3.20K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $3.20K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $3.20K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $8.90K 10-K · filed 2017-03-07 | |
| 2015-09-30 | $3.20K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $3.20K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $3.20K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $8.90K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $3.46K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $2.92K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $7.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $5.50K 10-K · filed 2015-02-27 | |
| 2013-09-30 | $3.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $2.75K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $1.50K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $5.50K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $1.50K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $1.50K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $1.50K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $5.50K 10-K · filed 2013-03-28 | |
| 2011-09-30 | $7.18K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $6.18K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $5.50K 10-K · filed 2012-03-30 | $8.32K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |